Abstract
Colorectal cancer (CRC) is the third most common cause of cancer worldwide. Recent studies have suggested that a dysbiotic shift in the intestinal microbial composition of CRC patients influences tumorigenesis. Gut microbes are known to be integral for intestinal homeostasis; however, the mechanisms by which they impact CRC are unclear. Further knowledge about these complex interactions may guide future CRC management. Thus, it is crucial to establish high-quality experimental models to understand the relationship between host, tumor, microbiota and their metabolic interactions. In this review, we highlight the significance of intestinal microbiota and their metabolites in CRC, challenges with current experimental models, advantages and limitations of organoid culture and future directions of this novel model system in CRC-associated microbiome research.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1583-1594 |
| Number of pages | 12 |
| Journal | Future Microbiology |
| Volume | 15 |
| Issue number | 16 |
| DOIs | |
| State | Published - Nov 2020 |
Bibliographical note
Funding Information:H Nalluri was supported, in part, by the Hubbard Broadcasting Foundation. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.
Publisher Copyright:
© 2020 Future Medicine Ltd.
Keywords
- 3D model
- colorectal cancer
- microbial metabolites
- microbiota
- organoid
- tumoroid
